Clinical trials: Childhood Mortality, open to volunteers

Mortality, Antimicrobial Resistance

Azithromycin for Child Survival in Niger II

• Recruiting
• Age: 1 month to 59 months
• Phase 4
• Pill or oral medicine

Several randomized controlled trials have demonstrated that azithromycin mass drug administration (MDA) reduces child mortality, but increases antimicrobial resistance (AMR).

Trial name

AVENIR II (NCT06358872)

Testing

Azithromycin for Oral Suspension

Where

Niger

Volunteers

3,300,000 people, healthy volunteers welcome

Sponsor

University of California, San Francisco